Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Connecticut Medicine
|
August 12, 2015
Updates on Clostridium Difficile Infection
Monika Zmarlicka, Michael D Nailor
Connecticut Medicine
|
December 20, 2012
Initial posaconazole prophylactic dosing and serum levels in heart transplant patients
Ana Delgado, Michael D Nailor
Pharmacotherapy
|
October 27, 2011
Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists
Natalie Boyd, Michael D Nailor
Therapeutic Advances in Drug Safety
|
June 15, 2016
Safety of high-dose doripenem in adult patients with cystic fibrosis
Seth Strawbridge, Michael D Nailor
Connecticut Medicine
|
May 13, 2016
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections
Rosanna Li, Michael D Nailor
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2023
Central Nervous System Infections and Antibiotic Selection: All Infection Sites Are Not Created Equal
Kellie J Goodlet, Michael D Nailor
Expert Review of Anti-Infective Therapy
|
June 6, 2007
Tinidazole for bacterial vaginosis
Michael D Nailor, Jack D Sobel
Expert Opinion on Investigational Drugs
|
April 28, 2007
Tinidazole for the treatment of vaginal infections
Michael D Nailor, Jack D Sobel
The Medical Clinics of North America
|
June 18, 2011
Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline
Michael D Nailor, Jack D Sobel
Connecticut Medicine
|
June 14, 2018
New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients
Samantha N Steiger, Michael D Nailor
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Connecticut Medicine
|
August 12, 2015
Updates on Clostridium Difficile Infection
Monika Zmarlicka, Michael D Nailor
Connecticut Medicine
|
December 20, 2012
Initial posaconazole prophylactic dosing and serum levels in heart transplant patients
Ana Delgado, Michael D Nailor
Pharmacotherapy
|
October 27, 2011
Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists
Natalie Boyd, Michael D Nailor
Therapeutic Advances in Drug Safety
|
June 15, 2016
Safety of high-dose doripenem in adult patients with cystic fibrosis
Seth Strawbridge, Michael D Nailor
Connecticut Medicine
|
May 13, 2016
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections
Rosanna Li, Michael D Nailor
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2023
Central Nervous System Infections and Antibiotic Selection: All Infection Sites Are Not Created Equal
Kellie J Goodlet, Michael D Nailor
Expert Review of Anti-Infective Therapy
|
June 6, 2007
Tinidazole for bacterial vaginosis
Michael D Nailor, Jack D Sobel
Expert Opinion on Investigational Drugs
|
April 28, 2007
Tinidazole for the treatment of vaginal infections
Michael D Nailor, Jack D Sobel
The Medical Clinics of North America
|
June 18, 2011
Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline
Michael D Nailor, Jack D Sobel
Connecticut Medicine
|
June 14, 2018
New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients
Samantha N Steiger, Michael D Nailor
Page
of 7